Alvotech

ALVO

Cena:

$ 3.42

+0.08 (2.40%)

Valuace

Růst

Zdraví

Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři

Souhrn

Finanční data

Pro investory

Předpovědi

Zprávy

Dividendy

Zisky

Návštěvnost webu

Akcionáři

Zprávy

Zahraniční články

Tiskové zprávy

Dokumenty ke stáhnutí

Alvotech (ALVO) Presents at Bank of America Global Healthcare Conference 2026 Transcript

21:00 13-05-2026

Alvotech (ALVO) Presents at Bank of America Global Healthcare Conference 2026 Transcript...

Alvotech Plans June FDA Resubmissions, Sees Biosimilar Approvals by Year-End

20:14 13-05-2026

Alvotech NASDAQ: ALVO Chief Strategy Officer Balaji Prasad said the biosimilar developer is preparin...

Alvotech Announces Completion of FDA Surveillance Inspection at Reykjavik Facility

4:30 11-05-2026

- Company remains on track for BLA resubmissions in the second quarter REYKJAVIK, Iceland, May 11, 2...

Alvotech (ALVO) Q1 2026 Earnings Call Transcript

22:41 07-05-2026

Alvotech (ALVO) Q1 2026 Earnings Call Transcript...

Alvotech (ALVO) Reports Q1 Loss, Lags Revenue Estimates

22:45 06-05-2026

Alvotech (ALVO) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimat...

Alvotech Q1 2026 Financial Results

16:30 06-05-2026

Alvotech (NASDAQ US: ALVO, ICELAND: ALVO, STOCKHOLM: ALVO SDB) Financial Highlights A supplemental...

Alvotech Announces a Change in its Executive Team

16:30 30-04-2026

REYKJAVIK, ICELAND (April 30, 2026) — Alvotech (NASDAQ: ALVO, the “Company”), a global biote...

Alvotech to Report Financial Results for the First Quarter of 2026

8:30 24-04-2026

REYKJAVIK, Iceland, April 24, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Com...

Alvotech to Report Financial Results for the First Quarter of 2026

8:30 24-04-2026

REYKJAVIK, ICELAND (April 24, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a g...

Alvotech (NASDAQ:ALVO) Receives Consensus Recommendation of “Hold” from Brokerages

4:44 21-04-2026

Shares of Alvotech (NASDAQ: ALVO - Get Free Report) have earned an average recommendation of "Hold" ...

Alvotech: Improving Fundamentals Signal A Potential Bottom For This Biosimilar Player

5:49 10-04-2026

Alvotech is rated a speculative buy with a $4 price target, implying over 12% upside from current le...

Alvotech files Annual Report with the SEC

19:58 30-03-2026

REYKJAVIK, ICELAND (March 30, 2026) — Alvotech (NASDAQ: ALVO) (the “Company”) has filed its ...

Alvotech Publishes 2025 Annual Report

19:55 30-03-2026

REYKJAVIK, ICELAND (March 30, 2026) — Alvotech (NASDAQ: ALVO) (the “Company”) has published ...

Brokerages Set Alvotech (NASDAQ:ALVO) Price Target at $7.60

5:32 30-03-2026

Shares of Alvotech (NASDAQ: ALVO - Get Free Report) have been assigned an average rating of "Hold" f...

Alvotech Q4 Earnings Call Highlights

1:02 21-03-2026

Alvotech (NASDAQ: ALVO) executives used the company's fourth-quarter and full-year 2025 earnings cal...

Alvotech (ALVO) Q4 2025 Earnings Call Transcript

15:12 19-03-2026

Alvotech (ALVO) Q4 2025 Earnings Call Transcript...

ALVO INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Alvotech

20:00 23-02-2026

NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP continues its invest...

ROSEN, LEADING INVESTOR COUNSEL, Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVO

18:49 11-02-2026

New York, New York--(Newsfile Corp. - February 11, 2026) - WHY: Rosen Law Firm, a global investor ri...

Alvotech Announces Increase in Number of Own Shares

11:00 11-02-2026

REYKJAVIK, ICELAND (February 11, 2026) — Alvotech (NASDAQ: ALVO) (the “Company”), a global b...

ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

16:08 09-02-2026

NEW YORK, Feb. 09, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,...

ROSEN, LEADING INVESTOR COUNSEL, ENCOURAGES ALVOTECH INVESTORS TO INQUIRE ABOUT SECURITIES CLASS ACTION INVESTIGATION - ALVO

11-02-2026

NEW YORK, NEW YORK--(NEWSFILE CORP. - FEBRUARY 11, 2026) - WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RI...

Více zde

ALVOTECH ANNOUNCES INCREASE IN NUMBER OF OWN SHARES

11-02-2026

REYKJAVIK, ICELAND (FEBRUARY 11, 2026) — ALVOTECH (NASDAQ: ALVO) (THE “COMPANY”), A GLOBAL B...

Více zde

ALVO INVESTOR NEWS: IF YOU HAVE SUFFERED LOSSES IN ALVOTECH (NASDAQ: ALVO), YOU ARE ENCOURAGED TO CONTACT THE ROSEN LAW FIRM ABOUT YOUR RIGHTS

09-02-2026

NEW YORK, FEB. 09, 2026 (GLOBE NEWSWIRE) -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM,...

Více zde

ROSEN LAW FIRM ENCOURAGES ALVOTECH INVESTORS TO INQUIRE ABOUT SECURITIES CLASS ACTION INVESTIGATION - ALVO

09-02-2026

NEW YORK, FEB. 9, 2026 /PRNEWSWIRE/ -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, CON...

Více zde

ALVO INVESTOR NEWS: IF YOU HAVE SUFFERED LOSSES IN ALVOTECH (NASDAQ: ALVO), YOU ARE ENCOURAGED TO CONTACT THE ROSEN LAW FIRM ABOUT YOUR RIGHTS

05-02-2026

NEW YORK, FEB. 05, 2026 (GLOBE NEWSWIRE) -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM,...

Více zde

ALVOTECH ANNOUNCES POSITIVE TOP-LINE RESULTS FROM PIVOTAL PHARMACOKINETIC STUDY FOR PROPOSED BIOSIMILAR TO ENTYVIO®

05-02-2026

REYKJAVIK, ICELAND, FEB. 05, 2026 (GLOBE NEWSWIRE) -- ALVOTECH (NASDAQ: ALVO), A GLOBAL BIOTECHNOLOG...

Více zde

ROSEN, A LEADING NATIONAL FIRM, ENCOURAGES ALVOTECH INVESTORS TO INQUIRE ABOUT SECURITIES CLASS ACTION INVESTIGATION - ALVO

04-02-2026

NEW YORK, NEW YORK--(NEWSFILE CORP. - FEBRUARY 4, 2026) - WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIG...

Více zde

ROSEN, TOP RANKED GLOBAL COUNSEL, ENCOURAGES ALVOTECH INVESTORS TO INQUIRE ABOUT SECURITIES CLASS ACTION INVESTIGATION - ALVO

03-02-2026

NEW YORK, NEW YORK--(NEWSFILE CORP. - FEBRUARY 3, 2026) - WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIG...

Více zde

ALVO INVESTOR NEWS: IF YOU HAVE SUFFERED LOSSES IN ALVOTECH (NASDAQ: ALVO), YOU ARE ENCOURAGED TO CONTACT THE ROSEN LAW FIRM ABOUT YOUR RIGHTS

02-02-2026

NEW YORK, FEB. 02, 2026 (GLOBE NEWSWIRE) -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM,...

Více zde

ALVOTECH ENTERS SUPPLY AND COMMERCIALIZATION AGREEMENTS FOR CANADA AND AUSTRALIA & NEW ZEALAND COVERING MULTIPLE BIOSIMILAR CANDIDATES

02-02-2026

REYKJAVIK, ICELAND, FEB. 02, 2026 (GLOBE NEWSWIRE) -- ALVOTECH (NASDAQ: ALVO), A GLOBAL BIOTECHNOLOG...

Více zde

ROSEN, TOP RANKED INVESTOR COUNSEL, ENCOURAGES ALVOTECH INVESTORS TO INQUIRE ABOUT SECURITIES CLASS ACTION INVESTIGATION - ALVO

29-01-2026

NEW YORK, NEW YORK--(NEWSFILE CORP. - JANUARY 29, 2026) - WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIG...

Více zde

ROSEN, A LONGSTANDING LAW FIRM, ENCOURAGES ALVOTECH INVESTORS TO INQUIRE ABOUT SECURITIES CLASS ACTION INVESTIGATION - ALVO

28-01-2026

NEW YORK, NEW YORK--(NEWSFILE CORP. - JANUARY 28, 2026) - WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIG...

Více zde

ROSEN, NATIONAL INVESTOR COUNSEL, ENCOURAGES ALVOTECH INVESTORS TO INQUIRE ABOUT SECURITIES CLASS ACTION INVESTIGATION - ALVO

22-01-2026

NEW YORK, NEW YORK--(NEWSFILE CORP. - JANUARY 22, 2026) - WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIG...

Více zde

ROSEN LAW FIRM ENCOURAGES ALVOTECH INVESTORS TO INQUIRE ABOUT SECURITIES CLASS ACTION INVESTIGATION - ALVO

20-01-2026

NEW YORK, JAN. 20, 2026 /PRNEWSWIRE/ -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, CON...

Více zde

ROSEN, SKILLED INVESTOR COUNSEL, ENCOURAGES ALVOTECH INVESTORS TO INQUIRE ABOUT SECURITIES CLASS ACTION INVESTIGATION - ALVO

18-01-2026

NEW YORK, NEW YORK--(NEWSFILE CORP. - JANUARY 18, 2026) - WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIG...

Více zde

ROSEN, LEADING TRIAL ATTORNEYS, ENCOURAGES ALVOTECH INVESTORS TO INQUIRE ABOUT SECURITIES CLASS ACTION INVESTIGATION - ALVO

17-01-2026

NEW YORK, NEW YORK--(NEWSFILE CORP. - JANUARY 17, 2026) - WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIG...

Více zde

ALVO INVESTOR NEWS: IF YOU HAVE SUFFERED LOSSES IN ALVOTECH (NASDAQ: ALVO), YOU ARE ENCOURAGED TO CONTACT THE ROSEN LAW FIRM ABOUT YOUR RIGHTS

16-01-2026

NEW YORK, JAN. 16, 2026 (GLOBE NEWSWIRE) -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM,...

Více zde

ROSEN LAW FIRM ENCOURAGES ALVOTECH INVESTORS TO INQUIRE ABOUT SECURITIES CLASS ACTION INVESTIGATION - ALVO

15-01-2026

NEW YORK, JAN. 15, 2026 /PRNEWSWIRE/ -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, CONT...

Více zde

ALVO INVESTOR ALERT: HAGENS BERMAN INVESTIGATES ALVOTECH (ALVO) FOR POTENTIAL SECURITIES FRAUD FOLLOWING MASSIVE FDA-INDUCED STOCK CRASH

14-01-2026

SAN FRANCISCO, JAN. 14, 2026 /PRNEWSWIRE/ -- NATIONAL SHAREHOLDER RIGHTS FIRM HAGENS BERMAN IS INVES...

Více zde

BRAGAR EAGEL & SQUIRE, P.C. CONTINUES INVESTIGATIONS INTO ALVOTECH AND BEYOND MEAT ON BEHALF OF STOCKHOLDERS AND ENCOURAGES INVESTORS TO CONTACT THE FIRM

13-01-2026

NEW YORK, JAN. 13, 2026 (GLOBE NEWSWIRE) -- BRAGAR EAGEL & SQUIRE, P.C., A NATIONALLY RECOGNIZED SHA...

Více zde

ALVO INVESTOR NEWS: IF YOU HAVE SUFFERED LOSSES IN ALVOTECH (NASDAQ: ALVO), YOU ARE ENCOURAGED TO CONTACT THE ROSEN LAW FIRM ABOUT YOUR RIGHTS

12-01-2026

NEW YORK, JAN. 12, 2026 (GLOBE NEWSWIRE) -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, ...

Více zde

ALVOTECH INVESTOR NEWS: ROSEN LAW FIRM ENCOURAGES ALVOTECH INVESTORS TO INQUIRE ABOUT SECURITIES CLASS ACTION INVESTIGATION - ALVO

10-01-2026

NEW YORK, JAN. 10, 2026 /PRNEWSWIRE/ -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, CONT...

Více zde

ALVO INVESTOR NEWS: IF YOU HAVE SUFFERED LOSSES IN ALVOTECH (NASDAQ: ALVO), YOU ARE ENCOURAGED TO CONTACT THE ROSEN LAW FIRM ABOUT YOUR RIGHTS

09-01-2026

NEW YORK, JAN. 09, 2026 (GLOBE NEWSWIRE) -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM,...

Více zde

CORRECTION: TRANSACTIONS OF MANAGERS AND CLOSELY ASSOCIATED PERSONS

07-01-2026

ATTACHED ARE COPIES OF TWO FILINGS WITH THE LUXEMBOURG COMMISSION DE SURVEILLANCE DU SECTEUR FINANCI...

Více zde

ALVO INVESTOR NEWS: IF YOU HAVE SUFFERED LOSSES IN ALVOTECH (NASDAQ: ALVO), YOU ARE ENCOURAGED TO CONTACT THE ROSEN LAW FIRM ABOUT YOUR RIGHTS

06-01-2026

NEW YORK, JAN. 06, 2026 (GLOBE NEWSWIRE) -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM,...

Více zde

TRANSACTIONS OF MANAGERS AND CLOSELY ASSOCIATED PERSONS

06-01-2026

ATTACHED IS A COPY OF A FILING WITH THE LUXEMBOURG COMMISSION DE SURVEILLANCE DU SECTEUR FINANCIER (...

Více zde

ALVO INVESTIGATION: INVESTORS ENCOURAGED TO CONTACT KIRBY MCINERNEY LLP

05-01-2026

NEW YORK--(BUSINESS WIRE)--THE LAW FIRM OF KIRBY MCINERNEY LLP REMINDS INVESTORS ITS INVESTIGATION O...

Více zde

ALVOTECH INVESTOR NEWS: ROSEN LAW FIRM ENCOURAGES ALVOTECH INVESTORS TO INQUIRE ABOUT SECURITIES CLASS ACTION INVESTIGATION - ALVO

05-01-2026

NEW YORK, JAN. 5, 2026 /PRNEWSWIRE/ -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, CONT...

Více zde

ALVO INVESTOR NEWS: IF YOU HAVE SUFFERED LOSSES IN ALVOTECH (NASDAQ: ALVO), YOU ARE ENCOURAGED TO CONTACT THE ROSEN LAW FIRM ABOUT YOUR RIGHTS

01-01-2026

NEW YORK, JAN. 01, 2026 (GLOBE NEWSWIRE) -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM,...

Více zde

ALVOTECH SECURES TERM LOAN FACILITY OF USD 100 MILLION

31-12-2025

REYKJAVIK, ICELAND, DEC. 31, 2025 (GLOBE NEWSWIRE) -- ALVOTECH (NASDAQ: ALVO), A GLOBAL BIOTECHNOLOG...

Více zde

Dokumenty nejsou k dispozici